Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Leukotide is a dietary supplement and nutraceutical product composed of a specific mixture of nucleotides, including adenosine, cytidine, guanosine, uridine, and inosine. It is primarily marketed to support the immune system by providing the necessary precursors for the rapid synthesis of leukocytes (white blood cells), which is particularly relevant during periods of physiological stress, infection, or recovery from medical treatments like chemotherapy. Nucleotides are essential for cell division and protein synthesis, and while the body can synthesize them de novo, exogenous supplementation is thought to reduce the metabolic burden on tissues with high turnover rates, such as the intestinal epithelium and immune cells. Leukotide is used in both human health contexts for immune support and in animal nutrition to improve growth and disease resistance in livestock and aquaculture.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Leukotide.